|
KEYNOTE-012: A phase Ib study of pembrolizumab (MK-3475) in patients (pts) with metastatic triple-negative breast cancer (mTNBC) |
|
|
|
Title: |
KEYNOTE-012: A phase Ib study of pembrolizumab (MK-3475) in patients (pts) with metastatic triple-negative breast cancer (mTNBC) |
Author: |
Buisseret, L. Specht, J. Dees, E.C. Berger, R. Gupta, S. Geva, R. Pusztai, L. Gause, C.K. Karantza, V. Nanda, R. |
Appeared in: |
Annals of oncology |
Paging: |
Volume 26 () nr. S3 pages iii6 |
Year: |
2015 |
Contents: |
|
Publisher: |
European Society for Medical Oncology |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|